Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subject...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT03417297 · Partial Seizures With Secondary Generalization, Focal Epilepsy With Secondary Generalization
NCT03283371 · Epilepsy, Focal Seizures, Partial Seizures
NCT03457961 · Focal Epilepsy, Generalized Epilepsy, and more
NCT00903786 · Refractory Partial Seizures
NCT01954121 · Epilepsy, Partial Seizures
Pfizer Investigational Site
Daegu
Pfizer Investigational Site
Daejeon
Pfizer Investigational Site
Gwangju
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions